The Alarming Mortality Rates of Congenital Heart Disease in Infants: Unveiling a Critical Need
The battle against congenital heart disease (CHD) has made significant strides, but a recent study reveals a startling truth: infants with CHD face the highest mortality rates, demanding urgent attention.
Research presented at the American Heart Association's 2025 Scientific Sessions sheds light on the ongoing challenges in CHD treatment. Despite being the most common congenital disorder, affecting approximately 0.8% of live births, CHD's impact is most devastating in infancy.
While technological advancements have significantly reduced morbidity and mortality rates, the survival of CHD patients into adulthood brings new complications. As the number of CHD survivors increases, the lack of comprehensive US-wide data on mortality rates becomes a pressing concern.
The STAR1 registry, a CDC-funded study, investigated CHD patients aged 0-45 from 7 states who had at least one healthcare encounter between 2010 and 2019. This study, presented by Dr. Allison Levin and colleagues at Duke University, revealed some eye-opening statistics.
Of the 218,863 patients included, 21% had severe CHD (sevCHD). The study found that 43% of the sevCHD group and 52% of the non-severe CHD (nsCHD) group were infants at the start. During the study, 3.2% of patients died, with 48% having sevCHD. The mortality rate for sevCHD patients was 7.6%, compared to 2.1% for nsCHD patients. Shockingly, these deaths accounted for around 60% and 55% of all deaths in their respective severity groups.
But here's where it gets controversial: the study also found that mortality rates remained consistently lower for nsCHD patients throughout their lives compared to sevCHD patients. And this is the part most people miss—the cause of death varied significantly. In the sevCHD group, cardiac issues were the primary cause, with CHD being the main culprit in younger patients, and a combination of CHD and acquired cardiovascular disease in older patients. By age 41, these acquired cardiovascular diseases and CHD accounted for approximately 40% of total mortality.
Heart failure emerged as the most common non-CHD cardiac cause of death, increasing with age. Interestingly, non-cardiac disease was the most common cause of death until age 30 in nsCHD patients, while acquired cardiovascular disease took over after that age.
The study's key takeaway? Infants with CHD, regardless of severity, face significantly higher mortality rates. Moreover, as patients age, CHD and acquired cardiovascular disease become the leading causes of death.
The researchers emphasize the critical need for specialized CHD care and cardiovascular preventive measures throughout patients' lives. This study serves as a call to action for healthcare professionals and policymakers to address this pressing issue.
